✦ LIBER ✦

Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature

✍ Scribed by Muhammed Sait Dag MD, Specialist…

Book ID: 120913048
Publisher: Springer Vienna
Year: 2013
Tongue: English
Weight: 200 KB
Volume: 125
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-013-0408-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon and ribavirin in a patient

Peginterferon and ribavirin in a patient with acute hepatitis C

✍ Santiago J. Rodríguez-Gómez; Carlos de la Serna-Higuera; Antonio Pérez-Villoria; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Peginterferon Alfa-2a in Patients with C

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis

✍ Heathcote, E. Jenny; Shiffman, Mitchell L.; Cooksley, W. Graham E.; Dusheiko, Ge 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 113 KB

792 CLINICAL AND PERSISTENCY OUTCOMES IN

792 CLINICAL AND PERSISTENCY OUTCOMES IN HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B PLUS RIBAVIRIN

✍ T.I. Hassanein; X. Ye; W.A. Blumentals; D.I. Brixner 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

W1017 Clinical and Persistency Outcomes

W1017 Clinical and Persistency Outcomes in Hepatitis C Patients Treated with Peginterferon Alfa-2a or Peginterferon Alfa-2b Plus Ribavirin

✍ Hassanein, Tarek; Ye, Xin; Chu, Teng-Chiao; Brixner, Diana 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Antiviral activity of telaprevir (VX-950

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

✍ Nicole Forestier; Hendrik W. Reesink; Christine J. Weegink; Lindsay McNair; Tara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Telaprevir (VX-950), an inhibitor of the hepatitis C virus (HCV) NS3/4A protease, substantially decreased plasma HCV RNA levels in a prior clinical study. The present study evaluated viral kinetics and safety during dosing with telaprevir alone and in combination with peginterferon alfa-2a for 14 da

Pharmacodynamics of peginterferon alfa-2

Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

✍ R. BRUNO; P. SACCHI; C. SCAGNOLARI; F. TORRIANI; L. MAIOCCHI; S. PATRUNO; F. BEL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB